Your browser doesn't support javascript.
loading
Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other.
Scherm, Martin G; Wyatt, Rebecca C; Serr, Isabelle; Anz, David; Richardson, Sarah J; Daniel, Carolin.
Affiliation
  • Scherm MG; Institute of Diabetes Research, Group Immune Tolerance Type 1 Diabetes, Helmholtz Diabetes Center at Helmholtz Zentrum München, Heidemannstrasse 1, 80939 Munich, Germany; Deutsches Zentrum für Diabetesforschung (DZD), Ingolstaedter Landstrasse 1, 85764 Munich-Neuherberg, Germany.
  • Wyatt RC; Islet Biology Group (IBEx), Exeter Centre of Excellence in Diabetes (EXCEED), University of Exeter College of Medicine and Health, Exeter EX2 5DW, UK.
  • Serr I; Institute of Diabetes Research, Group Immune Tolerance Type 1 Diabetes, Helmholtz Diabetes Center at Helmholtz Zentrum München, Heidemannstrasse 1, 80939 Munich, Germany; Deutsches Zentrum für Diabetesforschung (DZD), Ingolstaedter Landstrasse 1, 85764 Munich-Neuherberg, Germany.
  • Anz D; Department of Internal Medicine II (Gastroenterology and Hepatology), Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany; Division of Clinical Pharmacology, Department of Medicine IV, Ludwig-Maximilians-Universität München, 80337 Munich, Germany.
  • Richardson SJ; Islet Biology Group (IBEx), Exeter Centre of Excellence in Diabetes (EXCEED), University of Exeter College of Medicine and Health, Exeter EX2 5DW, UK.
  • Daniel C; Institute of Diabetes Research, Group Immune Tolerance Type 1 Diabetes, Helmholtz Diabetes Center at Helmholtz Zentrum München, Heidemannstrasse 1, 80939 Munich, Germany; Deutsches Zentrum für Diabetesforschung (DZD), Ingolstaedter Landstrasse 1, 85764 Munich-Neuherberg, Germany; Division of Clinica
Mol Metab ; 64: 101565, 2022 10.
Article de En | MEDLINE | ID: mdl-35944899
ABSTRACT

BACKGROUND:

The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell populations and the pancreatic islets. SCOPE OF REVIEW In this review article, we aim to discuss important recent insights into the multiple layers of interaction between immune cell populations and the pancreatic islets. Specifically, we discuss the environment where immune and beta cell interactions occur, the key cell types and molecules involved, and the outcomes of these interactions. MAJOR

CONCLUSIONS:

Most of the molecular mechanisms underlying aberrant immune cell activation and impaired immune tolerance remain insufficiently understood, which hinders the development of efficient prevention and treatment strategies. In order to overcome this knowledge gap, a better understanding of the complex interactions of immune cells and beta cells, including both the underlying protective and pathogenic mechanisms is urgently required.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ilots pancréatiques / Diabète de type 1 / Cellules à insuline Limites: Humans Langue: En Journal: Mol Metab Année: 2022 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ilots pancréatiques / Diabète de type 1 / Cellules à insuline Limites: Humans Langue: En Journal: Mol Metab Année: 2022 Type de document: Article Pays d'affiliation: Allemagne
...